Endogenous C1-inhibitor production and expression in the heart after acute myocardial infarction

Cardiovascular Pathology

Volumn 25, Issue 1, 2016, Pages 33-39

  Emmens, Reindert W ^a,b,c   Baylan, Umit ^a,b   Juffermans, Lynda J M ^a,b,d   Karia, Rashmi V ^a   Ylstra, Bauke ^a   Wouters, Diana ^c   Zeerleder, Sacha ^c,e   Simsek, Suat ^a,f   Van Ham, Marieke ^c   Niessen, Hans W M ^a,b   Krijnen, Paul A J ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c SANQUIN RESEARCH   (Netherlands)

^d INTERUNIVERSITY CARDIOLOGY INSTITUTE OF THE NETHERLANDS   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f Medical Centre Alkmaar   (Netherlands)

Author keywords

Acute myocardial infarction; C1 inhibitor; Complement; Ischemia

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C4D; MESSENGER RNA; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; PEPTIDE FRAGMENT; SERPING1 PROTEIN, HUMAN;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC PATIENT; CARDIOMYOBLAST; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GENE; HEART; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MYOBLAST; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MICROARRAY; PROTEIN SECRETION; RAT; RETROSPECTIVE STUDY; SERPING1 GENE; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; CARDIAC MUSCLE; CARDIAC MYOBLAST; CELL LINE; DISEASE MODEL; GENETICS; HEART INFARCTION; MALE; METABOLISM; NECROSIS; PATHOLOGY; TIME FACTOR; UPREGULATION; WISTAR RAT;

ANIMALS; CELL LINE; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C3D; COMPLEMENT C4B; DISEASE MODELS, ANIMAL; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MYOBLASTS, CARDIAC; MYOCARDIAL INFARCTION; MYOCARDIUM; NECROSIS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RETROSPECTIVE STUDIES; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

EID: 84951752675     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2015.09.006     Document Type: Article

References (35)

1. T Anzai Post-infarction inflammation and left ventricular remodeling: a double-edged sword Circ J 77 2013 580 587
2. JH Hill, and PA Ward The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats J Exp Med 133 1971 885 900
3. PR Maroko, CB Carpenter, M Chiariello, MC Fishbein, P Radvany, JD Knostman, and et al. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion J Clin Invest 61 1978 661 670
4. PA Krijnen, C Meischl, R Nijmeijer, CA Visser, CE Hack, and HW Niessen Inhibition of sPLA2-IIA, C-reactive protein or complement: new therapy for patients with acute myocardial infarction? Cardiovasc Hematol Disord Drug Targets 6 2006 113 123
5. C Martel, CB Granger, M Ghitescu, A Stebbins, A Fortier, PW Armstrong, and et al. Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial Am Heart J 164 2012 43 51
6. PK Smith, SK Shernan, JC Chen, M Carrier, ED Verrier, PX Adams, and et al. Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials J Thorac Cardiovasc Surg 142 2011 89 98
7. MH Kaplan, and JE Volanakis Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin J Immunol 112 1974 2135 2147
8. R Nijmeijer, WK Lagrand, YT Lubbers, CA Visser, CJ Meijer, HW Niessen, and et al. C-reactive protein activates complement in infarcted human myocardium Am J Pathol 163 2003 269 275
9. NA Daha, NK Banda, A Roos, FJ Beurskens, JM Bakker, MR Daha, and et al. Complement activation by (auto-) antibodies Mol Immunol 48 2011 1656 1665
10. PA Krijnen, C Ciurana, T Cramer, T Hazes, CJ Meijer, CA Visser, and et al. IgM colocalises with complement and C reactive protein in infarcted human myocardium J Clin Pathol 58 2005 382 388
11. Y Peng, R Kowalewski, S Kim, and KB Elkon The role of IgM antibodies in the recognition and clearance of apoptotic cells Mol Immunol 42 2005 781 787
12. JE Volanakis, and KW Wirtz Interaction of C-reactive protein with artificial phosphatidylcholine bilayers Nature 281 1979 155 157
13. R Nijmeijer, WK Lagrand, A Baidoshvili, YT Lubbers, WT Hermens, CJ Meijer, and et al. Secretory type II phospholipase A(2) binds to ischemic myocardium during myocardial infarction in humans Cardiovasc Res 53 2002 138 146
14. JF McDonald, and GL Nelsestuen Potent inhibition of terminal complement assembly by clusterin: characterization of its impact on C9 polymerization Biochemistry 36 1997 7464 7473
15. PA Krijnen, SA Cillessen, R Manoe, A Muller, CA Visser, CJ Meijer, and et al. Clusterin: a protective mediator for ischemic cardiomyocytes? Am J Physiol Heart Circ Physiol 289 2005 H2193 H2202
16. LA Trouw, SC Nilsson, I Goncalves, G Landberg, and AM Blom C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation J Exp Med 201 2005 1937 1948
17. LA Trouw, M Okroj, K Kupreishvili, G Landberg, B Johansson, HW Niessen, and et al. C4b-binding protein is present in affected areas of myocardial infarction during the acute inflammatory phase and covers a larger area than C3 PLoS One 3 2008 e2886
18. FK Kerr, AR Thomas, LC Wijeyewickrema, JC Whisstock, SE Boyd, D Kaiserman, and et al. Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor Mol Immunol 45 2008 670 677
19. RB Sim, GJ Arlaud, and MG Colomb C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes Biochem J 179 1979 449 457
20. C de Zwaan, AH Kleine, JH Diris, JF Glatz, HJ Wellens, PF Strengers, and et al. Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction Eur Heart J 23 2002 1670 1677
21. HW Niessen, WK Lagrand, CA Visser, CJ Meijer, and CE Hack Upregulation of ICAM-1 on cardiomyocytes in jeopardized human myocardium during infarction Cardiovasc Res 41 1999 603 610
22. LJ Juffermans, A van Dijk, CA Jongenelen, B Drukarch, A Reijerkerk, HE de Vries, and et al. Ultrasound and microbubble-induced intra- and intercellular bioeffects in primary endothelial cells Ultrasound Med Biol 35 2009 1917 1927
23. GK Smyth Limma: linear models for microarray data R Gentleman, V Carey, S Dudoit, R Irizarry, W Huber, Bioinformatics and Computational Biology Solutions using R and Bioconductor 2005 Springer New York 397 420
24. K Yasojima, C Schwab, EG McGeer, and PL McGeer Human heart generates complement proteins that are upregulated and activated after myocardial infarction Circ Res 83 1998 860 869
25. N Vesentini, C Barsanti, A Martino, C Kusmic, A Ripoli, AM Rossi, and et al. Selection of reference genes in different myocardial regions of an in vivo ischemia/reperfusion rat model for normalization of antioxidant gene expression BMC Res Notes 5 2012 124
26. AH Schmaier, SC Murray, GD Heda, A Farber, A Kuo, K McCrae, and et al. Synthesis and expression of C1 inhibitor by human umbilical vein endothelial cells J Biol Chem 264 1989 18173 18179
27. M Buerke, D Prufer, M Dahm, H Oelert, J Meyer, and H Darius Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury J Pharmacol Exp Ther 286 1998 429 438
28. J Fu, G Lin, B Zeng, Z Wu, Y Wu, H Chu, and et al. Anti-ischemia/reperfusion of C1 inhibitor in myocardial cell injury via regulation of local myocardial C3 activity Biochem Biophys Res Commun 350 2006 162 168
29. G Horstick, O Berg, A Heimann, O Gotze, M Loos, G Hafner, and et al. Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects Circulation 104 2001 3125 3131
30. K Fattouch, G Bianco, G Speziale, R Sampognaro, C Lavalle, F Guccione, and et al. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study Eur J Cardiothorac Surg 32 2007 326 332
31. WK Lagrand, HW Niessen, GJ Wolbink, LH Jaspars, CA Visser, FW Verheugt, and et al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction Circulation 95 1997 97 103
32. AE Prada, K Zahedi, and AE Davis Regulation of C1 inhibitor synthesis Immunobiology 199 1998 377 388
33. AM van der Laan, EN Ter Horst, R Delewi, MP Begieneman, PA Krijnen, A Hirsch, and et al. Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir Eur Heart J 35 2014 376 385
34. J Fu, G Lin, Z Wu, B Ceng, Y Wu, G Liang, and et al. Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury Biochem Biophys Res Commun 349 2006 504 512
35. D Liu, D Zhang, J Scafidi, X Wu, CC Cramer, and AE Davis C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeability Blood 105 2005 2350 2355